Braincures is a virtual biotech company that has unravelled the missing molecular links behind learning and memory to enable a low cost-high success drug discovery era. The molecular framework that powers the BRAINCURES Discovery Engine (BDE) does not require deep learning steps associated with AI approaches to turn data questions around compounds, genes, diseases and patient-treatment matching into actionable insights that enable an least 10-fold cost saving across all stages of discovery from target to precision medicine. Consequently, our biological intelligence approach is ready to provide outcomes that eliminate between 69 to 97% of projects associated with Phase III Clinical Failure and deliver an at least $11 billion dollar cost saving to the sponsors.